Epicrispr Reports Early Clinical Activity and Favorable Safety Profile in First-in-Human Epigenetic Editing Study for FSHD ...
Artelo Biosciences, Inc. announced positive results from its first-in-human study of ART26.12, a novel inhibitor of Fatty Acid Binding Protein 5 (FABP5) aimed at addressing unmet needs in pain ...
Sana Biotechnology reports six-month results from a first-in-human study demonstrating safe pancreatic islet cell transplantation for type 1 diabetes without immunosuppression. Sana Biotechnology ...
New Research Offers First Clinical Evidence of TPE’s Regenerative Effects in Humans, Co-Authored by Dr. Dobri Kiprov, Founder/President of Global Apheresis These findings confirm what we’ve long ...
Prospective study to evaluate diagnostic performance and generate real-world data for the Mitomic® Endometriosis Test, a non-invasive alternative to surgical diagnosis for endometriosis The study, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results